Pre-meeting symposium - 28th May 2025

Room 406 D - 28th May 2025

Pre-meeting Symposium: The Power of Collaboration: Multidisciplinary Updates on Liver Transplantation Challenges

Course Chair: Valeria Mas, PhD, MSc, FAST. President Elect

Part I: Advances in Cirrhosis, Acute Kidney Injury and Liver Transplantation—Updated Definitions, Pre-Transplant Strategies, and Allocation Policy

Moderator 1: Francois Durand (Hospital Beaujon, University Paris Cité, France ) (ILTS leadership/hepatologist)
Moderator 2: Tiffany Cho-Lam Wong (University of Hong Kong) (transplant surgeon)

Pre-meeting Symposium: The Power of Collaboration: Multidisciplinary Updates on Liver Transplantation Challenges
Part I: Advances in Cirrhosis, Acute Kidney Injury and Liver Transplantation—Updated Definitions, Pre-Transplant Strategies, and Allocation Policy

Main topics: Advances in Cirrhosis, AKI, and Liver Transplantation Hepatology track Cirrhosis, acute kidney injury and liver transplantation: Recent updates in definitions, pre-transplant management, allocation policy

1:00PM-1:15PM – New definitions of acute kidney injury in cirrhosis: International Club of Ascites (ICA) and the Acute Disease Quality Initiative (ADQI) multidisciplinary consensus
– Mitra K. Nadim (University of South California, Los Angeles, CA, USA)
1:15PM-1:30PM – Predicting Kidney Recovery After Liver Transplantation: Bridging Clinical Assessments and Biomarker Innovations
– Sumeet K Asrani, Baylor University Medical center, Dallas, TX, USA
1:30PM-1:45PM – Terlipressin in the treatment of hepatorenal syndrome as a bridge to liver transplantation
– Claire Francoz ( Hospital Beaujon, Clichy,France)
1:45PM-2:00PM – Advancing Kidney Care After Liver Transplantation: Tackling the New Era of SGLT2 Inhibitors and Novel Approaches
– Francois Durand (Hospital Beaujon, University Paris Cité, France )
2:00PM-2:15PM – PANEL DISCUSSION
2:15PM-2:45PM – Coffee break

Part II: Getting patients with ColoRectal Liver Metastasis or Intrahepatic Colangiocarcinoma ready for liver transplantation in Real World: Work-up and State of the Art Neoadjuvant Therapy

Moderator 1: Prashant Bhangui (ILTS leadership/transplant surgeon)
Moderator 2: Kevin Kim (University of Maryland School of Medicine, Baltimore, USA) (ILTS committee co- chair/interventional radiologist)

Pre-meeting Symposium: The Power of Collaboration: Multidisciplinary Updates on Liver Transplantation Challenges

Part II: Getting patients with ColoRectal Liver Metastasis or Intrahepatic Colangiocarcinoma ready for liver transplantation in Real World: Work-up and State of the Art Neoadjuvant Therapy

Main topics: Transplant oncology: multidisciplinary approach-DIAGNOSIS and basic knowledge on diagnosis, work up and neoadjuvant therapy for CRLM, diagnosis, work up and neoadjuvant therapy for ICC,

2:45PM-3:00PM – CRLM/ICC and LT: Current State in the US, Europe and Asia
– Christian Toso (University Hospitals of Geneva, Swiss)
3:00PM-3:15PM – Imaging diagnosis and treatment assessments on CRLM and ICC
– Lim Mei Chin (NUH Singapore)
3:15PM-3:30PM – Predictor/Prognosticator with AI on CRLM and ICC therapy, surgery and LT
– Gideon Ooi, Singapore General Hospital Singapore, Singapore.
3:30PM-3:45PM – Future role of LT in liver oncology
– Pal-Dag Line Institution: Oslo University Hospital, Oslo, Norway
3:45PM-4:00PM – PANEL DISCUSSION: Putting all together Case Presentations with Panel Discussion on ICC LT
4:00PM-4:15PM – Break

Part III: MASH and Transplantation – Emerging Therapies, Challenges, and Opportunities

Moderator 1: Nazia Selzner (ILTS leadership)
Moderator 2: Sarwa Darwish (Erasmus)

Pre-meeting Symposium: The Power of Collaboration: Multidisciplinary Updates on Liver Transplantation Challenges

Part III: MASH and Transplantation – Emerging Therapies, Challenges, and Opportunities

Main topics: landscape of MASH in liver transplantation, exploring new therapies, the intersection of MASH and hepatocellular carcinoma (HCC), living donor considerations, and recipient optimization strategies

4:15PM-4:30PM – Setting the Stage – MASH in the Liver Transplant Continuum
– Francesco Rosso, Italy
4:30PM-4:45PM – New Therapies, unmet needs and Future Outlook for MASH
– Mohamad Qasim Khan
4:45PM-5:00PM – MASH and HCC – With or Without Cirrhosis
– Daniel Huang, National University Hospital Singapore
5:00PM-5:30PM – Debate – Living Donor selection for MASH Patients: Should biological family members be considered?
– Pro Side: Dong Jin Joo, Yonsei University Hospital Cons Side: David Victor, Houston Methodist, Texas, USA
5:30PM-5:45PM – Recipient Optimization – Cardiovascular and Bariatric Interventions
– Julie Heimbach (Mayo Clinic)
5:45PM-6:00PM – PANEL DISCUSSION & Q&A

Room 406 D - 28th May 2025

Pre-meeting Symposium: The Power of Collaboration: Multidisciplinary Updates on Liver Transplantation Challenges

Part I: Advances in Cirrhosis, Acute Kidney Injury and Liver Transplantation—Updated Definitions, Pre-Transplant Strategies, and Allocation Policy

Part II: Getting patients with ColoRectal Liver Metastasis or Intrahepatic Colangiocarcinoma ready for liver transplantation in Real World: Work-up and State of the Art Neoadjuvant Therapy

Part III: MASH and Transplantation – Emerging Therapies, Challenges, and Opportunities

Sign up to our newsletter